EUVIMEDPoznaj EUVIMED
Open access · CC BY 4.0

Utilizing Constrained Bicyclic Peptides for In Vitro Diagnostics

André Shamsabadi, Adam Creamer, Christy J Sadler iD, Aida Abdelwahed, Katherine U Gaynor, Yuliya Demydchuk, Gabriela Ivanova-Berndt, Katerine Van Rietschoten iD, Paul Beswick, Liuhong Chen iD, Gustavo Arruda Bezerra iD, Aleksei Lulla and 4 more

ACS Nano · 2026

DOI: 10.1021/acsnano.5c19041 ↗

At a glance

Journal article in ACS Nano, 2026. Written by André Shamsabadi and 15 co-authors. Institution: Department of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K. Major MEDLINE topics: SARS-CoV-2, Peptides, Cyclic, COVID-19, Nucleocapsid Proteins. Cited 1 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Engineering and Physical Sciences Research Council, Royal Academy of Engineering, Innovate UK.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

High Resolution Image Download MS PowerPoint Slide Constrained bicyclic peptides ( Bicycle molecules ) with high affinity for biological targets have emerged as potentially powerful therapeutic agents, particularly for the in vivo targeting of cancer receptors. However, their antibody-mimetic properties have yet to be explored for use in diagnostic immunoassays. These synthetically derived compounds serve as biorecognition scaffolds that allow for facile site-selective modification and large-scale production. A phage display screen against various constructs of the SARS-CoV-2 nucleocapsid (N) protein identified several Bicycle molecules with binding affinities ranging from the micromolar to the low nanomolar range. These Bicycle molecules were validated in the development of enzyme- and nanozyme-linked immunosorbent assays, as well as enzymatic and colorimetric nanoparticle-based lateral flow immunoassays (LFIA) for the detection of ultralow concentrations of the SARS-CoV-2 N protein. We envision that these moieties enable robust, cost-effective, and large-scale development of ultrasensitive biosensors for a diverse range of biomarkers by leveraging their high binding affinity, minimalistic scaffold, and synthetic accessibility.

Subjects

MeSH terms (MEDLINE)

SARS-CoV-2Peptides, CyclicCOVID-19Nucleocapsid ProteinsHumansBiosensing TechniquesImmunoassayEnzyme-Linked Immunosorbent Assay

Author keywords

ELISALFIAantibody mimicbicyclic peptidesdiagnostics

Substances

Peptides, CyclicNucleocapsid Proteins

Authors and institutions

  • Department of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, U.K.
  • Bicycle Therapeutics, Portway Building, Granta Park, Cambridge CB21 6GS, U.K.
  • Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K.

ORCID profiles: Christy J Sadler, Katerine Van Rietschoten, Liuhong Chen, Gustavo Arruda Bezerra, Paul Brear, Marko Hyvönen, Michael J Skynner, Molly M Stevens

Funding

  • Engineering and Physical Sciences Research Council
  • Royal Academy of Engineering
  • Innovate UK
  • Rosetrees Trust
  • Cancer Research UK

Cite

APA

Shamsabadi, A., Creamer, A., Sadler, C. J., Abdelwahed, A., Gaynor, K. U., Demydchuk, Y., Ivanova-Berndt, G., Van Rietschoten, K., Beswick, P., Chen, L., Arruda Bezerra, G., Lulla, A., Brear, P., Hyvönen, M., Skynner, M. J., & Stevens, M. M. (2026). Utilizing Constrained Bicyclic Peptides for In Vitro Diagnostics. ACS Nano. https://doi.org/10.1021/acsnano.5c19041

Vancouver

Shamsabadi A, Creamer A, Sadler CJ, Abdelwahed A, Gaynor KU, Demydchuk Y, et al. Utilizing Constrained Bicyclic Peptides for In Vitro Diagnostics. ACS Nano. 2026. doi:10.1021/acsnano.5c19041

BibTeX
@article{Shamsabadi2026,
  author = {Shamsabadi, André and Creamer, Adam and Sadler, Christy J and Abdelwahed, Aida and Gaynor, Katherine U and Demydchuk, Yuliya and Ivanova-Berndt, Gabriela and Van Rietschoten, Katerine and Beswick, Paul and Chen, Liuhong and Arruda Bezerra, Gustavo and Lulla, Aleksei and Brear, Paul and Hyvönen, Marko and Skynner, Michael J and Stevens, Molly M},
  title = {Utilizing Constrained Bicyclic Peptides for In Vitro Diagnostics},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.5c19041}
}
Start for free →